Industry News
CSL named most respected life science company
Biotechnology major CSL was last week named Australia's most respected 'chemical/life sciences' company, appearing for the first time in the top 10 companies in the Australian Financial Review's 'Boss' magazine annual study. [ + ]
Mesoblast MPCs may extend stroke treatment window
Mesoblast's (ASX:MSB) detailed preclinical research suggests that its proprietary MPCs could improve recovery in ischemic stroke patients, even when injected up to seven days post stroke. [ + ]
Patrys's SM6 bound for new myeloma trial
Patrys (ASX:PAB) shares climbed 66% after the company announced a new combination study for one of its anticancer antibodies and the award of a US patent for another. [ + ]
ARC grant announcements
The Australian Research Council (ARC) Future Fellowships and Major Grants funding announcements for funding commencing in 2013 and 2014 were made last week. [ + ]
Workshop explores the challenge of taking stem cell therapy to market
The NSW Stem Cell Network is hosting a workshop to address the future of stem cell research in Australia and the gap in taking innovative stem cell therapies to patients. [ + ]
Trial confirms efficacy of Clinuvel drug in EPP
Clinuvel (ASX:CUV) said its Scenesse drug was able to relieve symptoms and improve quality of life in patients with rare genetic disease EPP during a phase III trial. [ + ]
World-first imaging system for cochlear implants
A world-first brain imaging system has been launched at the Australian Hearing Hub, located at Macquarie University. The system will allow researchers in the ARC Centre of Excellence in Cognition and its Disorders (CCD) and HEARing Cooperative Research Centre (CRC) to see how the information processed by cochlear implants is interpreted by the brain. [ + ]
Researchers create metamaterial lens with 10 times more power
Researchers at the University of Sydney have developed a lens with 10x the resolution of any other current lens. Writing about their work in the journal Nature Communications, the team explained that the lens is a metamaterial - a material with completely new properties not found in nature. [ + ]
MTAA awards achievements in medical technology
The Medical Technology Association of Australia (MTAA) last night held its annual conference dinner as part of the MedTech 2013 conference in Sydney, where the association presented two awards for achievements in medical technology. [ + ]
Immuron widens scope for liver treatment
Immuron (ASX:IMC) has received an approval to trial its IMM-124E in ASH as well as NASH, and animal studies support its utility in treating liver fibrosis. [ + ]
Government vetoes cap on self-education expenses
The federal government will not go ahead with a proposed cap on self-education expenses. [ + ]
Patrys antibody awarded orphan drug status in US
Patrys (ASX:PAB) now has orphan drug status for antibody PAT-SM6 in multiple myeloma covering the US as well as the EU. [ + ]
Body mass may be more nurture than nature
Genes have less influence on body mass than previously thought. [ + ]
South Australia's first autoimmune blood bank
Scientists from Flinders University and SA Pathology are setting up South Australia's first autoimmune blood bank, providing a central depository for research into different autoimmune diseases. [ + ]
Preparing for the world's largest radio telescope
The international Square Kilometre Array (SKA) office has awarded contracts to prepare for the world's largest radio telescope, marking the start of the return on Australia and WA's investment in the SKA. [ + ]
